AxoSim
Signal active
Organization
Contact Information
Overview
AxoSim is an operator of a biomimetic neuroscience discovery platform used to develop a 3D cell-based platform that looks and acts like a real nerve. The company empowers advancements in human neuroscience and accelerates the drug development process through its drug discovery platforms, NerveSim and BrainSim.
AxoSim was founded in 2014 and is based in New Orleans, Louisiana.
About
Industries
Biotechnology, Life Science, Medical, Biopharma, Neuroscience
Founded
2014
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
AxoSim headquartered in United States, North America, operates in the Biotechnology, Life Science, Medical, Biopharma, Neuroscience sector. The company focuses on Biotechnology and has secured $2.7B in funding across 260 round(s). With a team of 11-50 employees, AxoSim is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - AxoSim, raised $225.0K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
13
Investors
1
Lead Investors
0
Total Funding Amount
$10.5M
Details
5
AxoSim has raised a total of $10.5M in funding over 5 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Seed | |||
| 2017 | Seed | |||
| 2020 | Private Equity | |||
| 2021 | Early Stage Venture |
Investors
AxoSim is funded by 20 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| AxoSim | - | FUNDING ROUND - AxoSim | 230.0K |
| Center for the Advancement of Science in Space | - | FUNDING ROUND - Center for the Advancement of Science in Space | 230.0K |
| AxoSim | - | FUNDING ROUND - AxoSim | 225.0K |
| National Institutes of Health | - | FUNDING ROUND - National Institutes of Health | 225.0K |
Recent Activity
There is no recent news or activity for this profile.